Factor XI anti-sense oligonucleotide bests enoxaprin for venous thromboembolism in knee surgery
2 Minute Medicine ,
1. A factor XI anti-sense oligonucleotide, FXI-ASO, was associated with lower incidence of venous thromboembolism compared with…
1. A factor XI anti-sense oligonucleotide, FXI-ASO, was associated with lower incidence of venous thromboembolism compared with…
(HealthDay)—Reducing factor XI levels with a second-generation antisense oligonucleotide (FXI-ASO) is effective for preventing…
The first important results with a new drug under development by Isis Pharmaceuticals may well have an enormous long term…
Reducing factor XI levels with a second-generation antisense oligonucleotide (FXI-ASO) is effective for preventing venous…